Markets:

Overview

News

Currencies

International

Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.35 -0.22 (-1.90%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

32 33 Next >

New Study To Evaluate Magic Mushroom's Therapeutic Potential On Autistic Adults ↗

May 09, 2022

Psychedelics continue to garner attention as possible treatments for diverse mental health conditions. Now, Compass Pathways (NASDAQ: CMPS) will undertake a study to evaluate psilocybin’s effects on...

Via Benzinga

Psychedelic Stocks Continue To Decline In May ↗

May 08, 2022

The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue.

Via Talk Markets

TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today ↗

May 06, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16

Via Benzinga

GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗

May 05, 2022

GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS:

Via Benzinga

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today ↗

May 04, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30

Via Benzinga

2 New Studies Look At Compass Pathways' Psilocybin Drug For Anorexia And Depression ↗

May 03, 2022

Compass Pathways (Nasdaq: CMPS), a company developing psychedelic pharmaceutical drugs for the mental health space, announced the publication of two new investigator-initiated studies using its...

Via Benzinga

Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

May 03, 2022

GAINERS: Allied (OTC:ALID) shares closed up 5.27% at $0.76

Via Benzinga

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗

May 02, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80

Via Benzinga

Transcript: Jason Raznick's Conversation with Mr. Wonderful Kevin O'Leary At The Benzinga Psychedelics Conference ↗

May 02, 2022

On this special edition of the RazReport, Benzinga Founder & CEO Jason Raznick sits down with Kevin O'Leary AKA Mr. Wonderful at the Benzinga Psychedelics Capital...

Via Benzinga

Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

April 29, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 3.67% at $0.57 LOSERS:

Via Benzinga

Landmark Gathering Of Psychedelics Executives And Scientists To Take Place In London May 11 ↗

April 28, 2022

As the field of psychedelic medicine moves forward and international borders begin to open up, an expanding offering of conferences and live events are becoming available for investors, industry people...

Via Benzinga

Psychedelic Stock Gainers And Losers From April 28, 2022 ↗

April 28, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 4.35% at $1.20

Via Benzinga

Oregon to Become the First State to Legally Roll Out Psilocybin

April 28, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found in...

Via FinancialNewsMedia

Topics Derivatives ETFs

Psychedelic Stock Gainers And Losers From April 27, 2022 ↗

April 27, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.77% at $0.28

Via Benzinga

Psychedelic Stock Gainers And Losers From April 26, 2022 ↗

April 26, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.61% at $0.29

Via Benzinga

ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗

April 25, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.97% at $4.97

Via Benzinga

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...

Via Benzinga

Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today ↗

April 22, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 3.49% at $0.87

Via Benzinga

Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 21, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 20.83% at $0.29

Via Benzinga

Psychedelic Stock Gainers And Losers From April 20, 2022 ↗

April 20, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS:

Via Benzinga

Compass Pathways Partners With One Mind To Fund Rising Star Awards ↗

April 20, 2022

Compass Pathways plc (NASDAQ:CMPS) and California-based non-profit organization One Mind partnered to sponsor three “2022 One Mind - COMPASS Rising Stars Awards.”

Via Benzinga

Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗

April 19, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.57% at $0.33

Via Benzinga

EXCLUSIVE: ATAI Life Sciences Deploys Decentralized Approach To Transform Mental Health Treatments ↗

April 19, 2022

ATAI Life Sciences NV (NASDAQ: ATAI) is deploying a multipronged approach to accelerate the development of mental health treatments.

Via Benzinga

EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments ↗

April 19, 2022

For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging...

Via Benzinga

EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge ↗

April 19, 2022

The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday.

Via Benzinga

Psychedelic Stock Gainers And Losers From April 18, 2022 ↗

April 18, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.66% at $0.28

Via Benzinga

Psychedelic Stock Gainers And Losers From April 14, 2022 ↗

April 14, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.50% at $5.32

Via Benzinga

Psychedelic Stock Gainers And Losers From April 13, 2022 ↗

April 13, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.41% at $0.24

Via Benzinga

Why Psychedelics Could Soon Replace Antidepressants

April 13, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...

Via FinancialNewsMedia

Psychedelic Stock Gainers And Losers From April 11, 2022 ↗

April 11, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.52% at $0.17

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.